Total Payments
$3,636
2023 Payments
$49.68
Companies
32
Transactions
249
Medicare Patients
3,209
Medicare Billing
$177,915
Payment Breakdown by Category
Food & Beverage$3,636 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,636 | 249 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $355.00 | 27 | $0 (2022) |
| ABBVIE INC. | $340.83 | 31 | $0 (2022) |
| Novo Nordisk Inc | $315.18 | 27 | $0 (2022) |
| Lilly USA, LLC | $289.06 | 19 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $218.00 | 10 | $0 (2023) |
| Allergan, Inc. | $216.25 | 15 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $211.72 | 10 | $0 (2022) |
| Astellas Pharma US Inc | $168.27 | 10 | $0 (2020) |
| Merck Sharp & Dohme LLC | $151.03 | 8 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $143.70 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $49.68 | 3 | Dexcom, Inc. ($34.68) |
| 2022 | $455.61 | 26 | E.R. Squibb & Sons, L.L.C. ($124.97) |
| 2021 | $899.73 | 66 | AbbVie Inc. ($284.83) |
| 2020 | $504.86 | 32 | Allergan, Inc. ($205.25) |
| 2019 | $610.39 | 48 | AstraZeneca Pharmaceuticals LP ($113.11) |
| 2018 | $588.37 | 36 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($94.03) |
| 2017 | $527.81 | 38 | Novo Nordisk Inc ($94.80) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Endocrinology | ||||||
| 04/21/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Endocrinology | ||||||
| 04/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Gastroenterology | ||||||
| 12/02/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Endocrinology | ||||||
| 11/09/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PROQUAD, VAXELIS | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: VACCINE | ||||||
| 09/07/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.93 | General |
| Category: Cardiovascular | ||||||
| 08/31/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: UROLOGY | ||||||
| 08/25/2022 | Seqirus USA Inc | Fluad Quadrivalent (Biological), FLUCELVAX QUADRIVALENT | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Vaccines | ||||||
| 08/03/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.59 | General |
| Category: Cardiovascular | ||||||
| 07/13/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/06/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Respiratory | ||||||
| 06/29/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/15/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/13/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Diabetes | ||||||
| 05/13/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Endocrinology | ||||||
| 04/27/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/27/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Gastroenterology | ||||||
| 04/22/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.84 | General |
| Category: Cardiovascular | ||||||
| 04/20/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Endocrinology | ||||||
| 03/16/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/12/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/09/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Diabetes | ||||||
| 02/23/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $44.30 | General |
| 02/23/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.31 | General |
| Category: Cardiovascular | ||||||
| 02/11/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 12 | 908 | 1,374 | $126,040 | $58,587 |
| 2021 | 21 | 1,236 | 1,789 | $142,391 | $65,425 |
| 2020 | 17 | 1,065 | 1,684 | $143,140 | $53,903 |
Total Patients
3,209
Total Services
4,847
Medicare Billing
$177,915
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 204 | 363 | $65,340 | $29,369 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 155 | 219 | $28,470 | $12,842 | 45.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 21 | 24 | $8,400 | $5,394 | 64.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 99 | 99 | $2,970 | $2,860 | 96.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 51 | 65 | $4,550 | $2,523 | 55.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 70 | 70 | $2,100 | $1,476 | 70.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 22 | 90 | $3,150 | $1,370 | 43.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 188 | 322 | $6,440 | $953.85 | 14.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 23 | 24 | $2,400 | $843.00 | 35.1% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 29 | 29 | $870.00 | $581.55 | 66.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 21 | 22 | $880.00 | $211.67 | 24.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 25 | 47 | $470.00 | $161.69 | 34.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 207 | 345 | $62,100 | $25,793 | 41.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 150 | 250 | $32,500 | $15,882 | 48.9% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 19 | 24 | $8,400 | $5,428 | 64.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 66 | 92 | $6,440 | $3,073 | 47.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 18 | 18 | $3,600 | $2,429 | 67.5% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 62 | 62 | $2,480 | $2,425 | 97.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 125 | 126 | $3,780 | $2,104 | 55.7% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 96 | 97 | $2,910 | $1,989 | 68.3% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 19 | 81 | $2,835 | $1,286 | 45.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 205 | 350 | $7,000 | $1,046 | 14.9% |
| 87428 | Sarscov & inf vir a&b ag ia | Office | 2021 | 11 | 13 | $2,275 | $826.67 | 36.3% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 17 | 18 | $1,800 | $635.94 | 35.3% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 30 | 30 | $900.00 | $577.39 | 64.2% |
About Dr. Paul Reger, MD
Dr. Paul Reger, MD is a Family Medicine healthcare provider based in Mascoutah, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003922709.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Reger, MD has received a total of $3,636 in payments from pharmaceutical and medical device companies, with $49.68 received in 2023. These payments were reported across 249 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,636).
As a Medicare-enrolled provider, Reger has provided services to 3,209 Medicare beneficiaries, totaling 4,847 services with total Medicare billing of $177,915. Data is available for 3 years (2020–2022), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Mascoutah, IL
- Active Since 08/23/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003922709
Products in Payments
- UBRELVY (Drug) $286.72
- TRULICITY (Drug) $247.30
- FARXIGA (Drug) $226.50
- XIFAXAN (Drug) $219.19
- VRAYLAR (Drug) $187.19
- ELIQUIS (Drug) $183.85
- XARELTO (Drug) $125.08
- Ozempic (Drug) $118.81
- Livalo (Drug) $111.21
- Victoza (Drug) $94.80
- MYRBETRIQ (Drug) $89.11
- SYMBICORT (Drug) $84.64
- Dexcom G6 Transmitter (Medical Supply) $80.57
- Trintellix (Drug) $73.90
- JANUVIA (Drug) $73.43
- SOLIQUA 100/33 (Biological) $71.68
- ENTRESTO (Drug) $64.51
- Tresiba (Drug) $63.25
- Aimovig (Biological) $60.08
- Vascepa (Drug) $49.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.